Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Pain, Postoperative

In brief

This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.

Key facts

Study ID

NCT02959996

Run by

Massachusetts General Hospital

People needed

80

Starts

2017-03-08

Expected to finish

2017-11-03

Last updated by the study team

2018-08-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled cesarean delivery via Pfannenstiel incision;
• Planned neuraxial anesthetic with intrathecal morphine and fentanyl administration.

You may not qualify if…

• Current or prior use of methadone, buprenorphine, or other opioids before cesarean delivery;
• Contraindication to neuraxial anesthetic;
• Allergy to local anesthetic;
• Planned general anesthetic.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.